Earningsreport

Q1/2024 3/31/2024 EPS -0.340 ZacksConsensus -0.360 ActVsEst 0.020 - Beat

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors